Abstract
Calcium channel blockers are widely used for the treatment of hypertension. Although they are effective for their strong vasodilator action, there are concerns regarding related baroreflex-mediated activation of sympathetic nervous system. However, long-acting calcium channel blockers, such as amlodipine, are now known safe for the treatment of hypertension. Furthermore, the new type of calcium channel blockers, such as cilnidipine with N-type calcium channel blocking action, or azelnidipine that has sympatho-inhibitory action with anti-oxidant effect, provide a new insight for the future use of calcium channel blockers.
Original language | English |
---|---|
Pages (from-to) | 32-37 |
Number of pages | 6 |
Journal | Clinical calcium |
Volume | 20 |
Issue number | 1 |
Publication status | Published - Jan 2010 |
All Science Journal Classification (ASJC) codes
- Medicine(all)